Eli Lilly stock will surge 29% over the next year with its weight-loss drug on pace to do $60 billion in sales by 2030, BofA says

1.99 Eli Lilly stock will surge 29% over the next year with its weight-loss drug on pace to do $60 billion in sales by 2030, BofA says

Friss hírek egy helyen.

bulvárhírek

gazdasági hírek

autós hírek

életmód hírek

sporthírek

<< vissza

Eli Lilly stock will surge 29% over the next year with its weight-loss drug on pace to do $60 billion in sales by 2030, BofA says
Dátum: 2024-03-02 [news.yahoo.com]

A TELJES HÍR ELOLVASÁSA >>